Clinical Trial Update: Study Evaluating the Efficacy and Safety of Triptergium Wilfordii and Acitretin in Psoriasis Vulgaris - CHINA201002016-2 [Phase 4]

View source ↗

Summary

Clinical trial update evaluating the efficacy and safety of Tripterygium wilfordii and acitretin in psoriasis, in a Phase 4 study conducted in China.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Acitretin (Acitretin)
• Tripterygium wilfordii (Tripterygium wilfordii)

Snippet

Sponsor: Ministry of Health, China | Conditions: Psoriasis Vulgaris | Phase 4 | Status: UNKNOWN